Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Horsman

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressureM R Horsman, K L Christensen, J Overgaard
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1989
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivoM R Horsman, K L Christensen, J Overgaard
International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation statusM R Horsman, P V Hansen, J Overgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1989
Misonidazole chemosensitization of EMT6 spheroids to melphalanM R Horsman, P J Wood, J M Brown
British Journal of Cancer|August 1, 1993
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeD J Chaplin, M R Horsman, D W Siemann
Cancer Investigation|September 6, 2017
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat CancerD W Siemann, D J Chaplin, M R Horsman
Biomedica Biochimica Acta|January 1, 1989
Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapyD J Chaplin, B D Acker, M R Horsman
British Journal of Cancer|January 1, 1991
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoD J Chaplin, M R Horsman, D S Aoki
Journal of the National Cancer Institute|April 18, 1990
Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumorD J Chaplin, M R Horsman, M J Trotter
British Journal of Cancer|December 1, 1995
Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumoursM R Horsman, M Nordsmark, M Høyer, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressureM R Horsman, K L Christensen, J Overgaard
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1989
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivoM R Horsman, K L Christensen, J Overgaard
International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation statusM R Horsman, P V Hansen, J Overgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1989
Misonidazole chemosensitization of EMT6 spheroids to melphalanM R Horsman, P J Wood, J M Brown
British Journal of Cancer|August 1, 1993
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeD J Chaplin, M R Horsman, D W Siemann
Cancer Investigation|September 6, 2017
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat CancerD W Siemann, D J Chaplin, M R Horsman
Biomedica Biochimica Acta|January 1, 1989
Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapyD J Chaplin, B D Acker, M R Horsman
British Journal of Cancer|January 1, 1991
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoD J Chaplin, M R Horsman, D S Aoki
Journal of the National Cancer Institute|April 18, 1990
Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumorD J Chaplin, M R Horsman, M J Trotter
British Journal of Cancer|December 1, 1995
Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumoursM R Horsman, M Nordsmark, M Høyer, et al.
Pageof 11